DOI: 10.12890/2021_002782

The Development of Ecchymosis after Administration of Convalescent Serum in a Patient with COVID-19 Associated with Thrombocytosis

Authors

  • Rajashree Khot Department of General Medicine, AIIMS, Nagpur, Maharashtra, India
  • Sunita Kumbhalkar Department of General Medicine, AIIMS, Nagpur, Maharashtra, India
  • Richa Juneja Department of Pathology (Haematology), AIIMS, Nagpur, Maharashtra, India
  • Prashant P Joshi Department of General Medicine, AIIMS, Nagpur, Maharashtra, India

rajashree.s.khot@gmail.com

Keywords

COVID-19, thrombocytosis, convalescent plasma reaction, ecchymoses

Abstract

COVID-19 can have an unpredictable and severe course, leading to many hypotheses regarding its pathophysiology and clinical manifestations. Haematological manifestations are a significant predictor of disease severity. The most common observation is lymphopenia with an increased neutrophil:lymphocyte ratio. Platelets have been implicated in thrombogenic events, but the most frequently reported abnormality is mild thrombocytopenia.<br />
Here we present an interesting case of a patient with moderate COVID-19 who presented with cutaneous ecchymoses and thrombocytosis, and discuss this paradox.

View the entire article

Downloads

References

  1. Comer SP, Cullivan S, Szklanna PB, Weiss L, Cullen S, Kelliher S, et al. COVID-19 induces a hyperactive phenotype in circulating platelets. PLoS Biol 2021;19(2):e3001109. doi: 10.1371/journal.pbio.3001109.
  2. Nagoba B, Gavkare A, Jamadar N, Mumbre S, Selkar S. Positive aspects, negative aspects and limitations of plasma therapy with special reference to COVID-19. J Infect Public Health 2020;13:1818–1822.
  3. Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood x2020;136(4):489–500. doi: 10.1182/blood.2020006520.
  4. Jiang SQ, Huang QF, Xie WM, Lv C, Quan XQ. The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants. Br J Haematol 2020;190(1):e29–33.

Published

2021-10-08

How to Cite

1.
Khot R, Kumbhalkar S, Juneja R, Joshi PP. The Development of Ecchymosis after Administration of Convalescent Serum in a Patient with COVID-19 Associated with Thrombocytosis. EJCRIM [Internet]. 2021 Oct. 8 [cited 2026 Nov. 3];8(9). Available from: https://ejcrim.com/index.php/ejcrim/article/view/2782